The CD44+/CD24-phenotype is enriched in basal-like breast tumors G Honeth, PO Bendahl, M Ringnér, LH Saal, SK Gruvberger-Saal, ... Breast Cancer Research 10, 1-12, 2008 | 711 | 2008 |
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers E Olsson, G Honeth, PO Bendahl, LH Saal, S Gruvberger-Saal, M Ringnér, ... BMC cancer 11, 1-13, 2011 | 242 | 2011 |
A novel model of dormancy for bone metastatic breast cancer cells R Marlow, G Honeth, S Lombardi, M Cariati, S Hessey, A Pipili, V Mariotti, ... Cancer research 73 (23), 6886-6899, 2013 | 142 | 2013 |
α10 Integrin Expression Is Up-Regulated on Fibroblast Growth Factor-2-Treated Mesenchymal Stem Cells with Improved Chondrogenic Differentiation Potential L Varas, LB Ohlsson, G Honeth, A Olsson, T Bengtsson, C Wiberg, ... Stem cells and development 16 (6), 965-978, 2007 | 120 | 2007 |
Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo K Staflin, G Honeth, S Kalliomäki, C Kjellman, K Edvardsen, M Lindvall Cancer research 64 (15), 5347-5354, 2004 | 109 | 2004 |
Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer K Rennstam, N McMichael, P Berglund, G Honeth, C Hegardt, L Rydén, ... Breast cancer research and treatment 122, 315-324, 2010 | 108 | 2010 |
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium G Honeth, S Lombardi, C Ginestier, M Hur, R Marlow, B Buchupalli, ... Breast Cancer Research 16, 1-14, 2014 | 61 | 2014 |
Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells S Lombardi, G Honeth, C Ginestier, I Shinomiya, R Marlow, B Buchupalli, ... Stem cell reports 2 (6), 780-793, 2014 | 58 | 2014 |
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer CL Alves, S Ehmsen, MG Terp, N Portman, M Tuttolomondo, ... Nature Communications 12 (1), 5112, 2021 | 52 | 2021 |
Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma G Honeth, K Staflin, S Kalliomäki, M Lindvall, C Kjellman Experimental cell research 312 (8), 1265-1276, 2006 | 49 | 2006 |
Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer M Cieśla, PCT Ngoc, E Cordero, ÁS Martinez, M Morsing, S Muthukumar, ... Molecular cell 81 (7), 1453-1468. e12, 2021 | 44 | 2021 |
Identification of proteins involved in neural progenitor cell targeting of gliomas K Staflin, T Zuchner, G Honeth, A Darabi, C Lundberg BMC cancer 9, 1-14, 2009 | 38 | 2009 |
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer K Kaminska, N Akrap, J Staaf, CL Alves, A Ehinger, A Ebbesson, ... Breast Cancer Research 23, 1-18, 2021 | 33 | 2021 |
Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule G Honeth, T Schiavinotto, F Vaggi, R Marlow, T Kanno, I Shinomiya, ... Stem Cell Reports 4 (4), 699-711, 2015 | 33 | 2015 |
Reduction of the putative CD44+ CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047 H Cirenajwis, S Smiljanic, G Honeth, C Hegardt, LJ Marton, SM Oredsson Anti-cancer drugs 21 (10), 897-906, 2010 | 31 | 2010 |
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent M Sjöström, L Hartman, G Honeth, D Grabau, P Malmström, C Hegardt, ... Journal of Clinical Pathology 68 (12), 1012-1019, 2015 | 22 | 2015 |
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian … K Staflin, S Järnum, J Hua, G Honeth, P Kannisto, M Lindvall International Journal of Gynecologic Cancer 16 (4), 2006 | 17 | 2006 |
Identification and characterization of a human smad3 splicing variant lacking part of the linker region C Kjellman, G Honeth, S Järnum, M Lindvall, A Darabi, I Nilsson, ... Gene 327 (2), 141-152, 2004 | 15 | 2004 |
Met expression and cancer stem cell networks impact outcome in high-grade serous ovarian cancer M Bååth, JM Jönsson, S Westbom Fremer, L Martín de la Fuente, L Tran, ... Genes 12 (5), 742, 2021 | 6 | 2021 |
Fulvestrant resistance in estrogen receptor positive breast cancer models is driven by heterogeneous ER independent transcriptional programs KK Kaminska, N Akrap, J Staaf, Å Borg, A Bosch, G Honeth Cancer Research 78 (13_Supplement), 5907-5907, 2018 | 4 | 2018 |